Viscosupplementation Market Regional Analysis:
North America Market Insights
The North American viscosupplementation market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the increasing geriatric population, escalating preference for short treatment schedules, and the growing occurrence of osteoarthritis in the region. According to the data released by the Centers for Disease Control and Prevention, by 2020, more than 32.5 million adults in the United States had osteoarthritis. Furthermore, it was also projected that more than 95 million Americans are living with knee pain and require VS therapies to cure the pain, and more than 25%, summing up to 58 million people, in the United States have arthritis. It is stated that knee pain is the 2nd leading pain to cause of chronic pain in people. For instance, knee pain also affects around 22% of adults in the region. Therefore, viscosupplementation treatment is highly required in the region since arthritis increases work disability. For instance, the cost of Medicare and lost earnings in the region are projected to be around USD 300 billion every year in this region. Hence, all these factors are anticipated to expand the viscosupplementation market size in the region over the forecast period.
Asia Pacific Market Insights
Furthermore, the viscosupplementation market is also expected to obtain notable growth in the Asia Pacific region of the back higher prevalence of arthritis backed by the significant growth in the geriatric population. For instance, approximately 400 million people in Asia were expected to be aged above 65 in 2020, while China and India accounted for 1 billion each. The number of geriatrics in the region was projected to near 18% higher than in the USA. Geriatrics suffer from severe knee problems. Therefore, this factor is expected to boost the growth of the market in the region over the forecast period.
